SCHEMBL8065950

SCHEMBL8065950

Cc1ccc(/C=C/C(=O)Nc2cc(Cl)ccc2C(=O)O)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.70
KCNK2 O95069 1/20 0.69
TRPA1 O75762 4/20 0.64
POLB P06746 3/20 0.60
TRPM2 O94759 3/20 0.60
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
MAPT P10636 3/20 0.60
ALDH1A1 P00352 3/20 0.60
HPGD P15428 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
EGFR P00533 1/20 0.55
KDM4E B2RXH2 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
RAB9A P51151 3/20 0.53
LMNA P02545 2/20 0.53
NPC1 O15118 2/20 0.53
LTB4R Q15722 1/20 0.52
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8065953 1.00 TP53 (0.70) TP53KCNK2TRPA1POLBTRPM2
SCHEMBL8061586 0.92 TRPA1 (0.75) TP53KCNK2TRPA1POLBTRPM2
SCHEMBL8061590 0.92 TRPA1 (0.75) TP53KCNK2TRPA1POLBTRPM2
SCHEMBL8064019 0.90 TP53 (0.74) TP53KCNK2TRPA1POLBTRPM2
SCHEMBL8064022 0.90 TP53 (0.74) TP53KCNK2TRPA1POLBTRPM2
SCHEMBL8060354 0.88 TRPA1 (0.73) KCNK2TRPA1POLBTRPM2MEN1
SCHEMBL8060350 0.88 TRPA1 (0.73) KCNK2TRPA1POLBTRPM2MEN1
SCHEMBL8150084 0.87 TRPA1 (0.68) TP53KCNK2TRPA1POLBTRPM2
SCHEMBL8061601 0.87 TRPA1 (0.68) TP53KCNK2TRPA1POLBTRPM2
SCHEMBL8061788 0.87 TRPA1 (0.68) TP53KCNK2TRPA1POLBTRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed